CbdMD Research Development from 2010 to 2026
| YCBD Stock | USD 0.92 0.02 2.13% |
Research Development | First Reported 2019-03-31 | Previous Quarter 9.6 K | Current Value 15 K | Quarterly Volatility 164.2 K |
Check CbdMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CbdMD's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 98.9 K or Interest Expense of 32.2 K, as well as many indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.21 or PTB Ratio of 7.0E-4. CbdMD financial statements analysis is a perfect complement when working with CbdMD Valuation or Volatility modules.
CbdMD | Research Development | Build AI portfolio with CbdMD Stock |
Analyzing CbdMD's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing CbdMD's current valuation and future prospects.
Latest CbdMD's Research Development Growth Pattern
Below is the plot of the Research Development of cbdMD Inc over the last few years. It is CbdMD's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CbdMD's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
CbdMD Research Development Regression Statistics
| Arithmetic Mean | 388,589 | |
| Geometric Mean | 242,419 | |
| Coefficient Of Variation | 83.75 | |
| Mean Deviation | 192,660 | |
| Median | 424,450 | |
| Standard Deviation | 325,428 | |
| Sample Variance | 105.9B | |
| Range | 1.4M | |
| R-Value | (0.33) | |
| Mean Square Error | 100.9B | |
| R-Squared | 0.11 | |
| Significance | 0.20 | |
| Slope | (21,016) | |
| Total Sum of Squares | 1.7T |
CbdMD Research Development History
About CbdMD Financial Statements
CbdMD stakeholders use historical fundamental indicators, such as CbdMD's Research Development, to determine how well the company is positioned to perform in the future. Although CbdMD investors may analyze each financial statement separately, they are all interrelated. For example, changes in CbdMD's assets and liabilities are reflected in the revenues and expenses on CbdMD's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in cbdMD Inc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 30.5 K | 28.9 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether cbdMD Inc is a strong investment it is important to analyze CbdMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CbdMD's future performance. For an informed investment choice regarding CbdMD Stock, refer to the following important reports:Check out the analysis of CbdMD Correlation against competitors. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Will Pharmaceuticals sector continue expanding? Could CbdMD diversify its offerings? Factors like these will boost the valuation of CbdMD. Anticipated expansion of CbdMD directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CbdMD data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.51 | Revenue Per Share | Quarterly Revenue Growth (0.11) | Return On Assets | Return On Equity |
cbdMD Inc's market price often diverges from its book value, the accounting figure shown on CbdMD's balance sheet. Smart investors calculate CbdMD's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CbdMD's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between CbdMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if CbdMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CbdMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.